Niroshan Nadarajah Selected Research

Niroshan Nadarajah Research Topics

6	Neoplasms (Cancer) 01/2023 - 02/2016
3	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 04/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 05/2012
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2024
1	idiopathic Aplastic anemia 01/2023
1	Stroke (Strokes) 01/2023
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2023
1	Lymphoma (Lymphomas) 01/2022
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022
1	Residual Neoplasm 11/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016

3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 02/2016
2	RNA Splicing FactorsIBA 01/2021 - 01/2020
1	OMS 2017IBA 03/2024
1	AntigensIBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	Amino Acids FDA Link 01/2022
1	Mutant Proteins (Protein, Mutant)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	RNA Precursors (Precursor, mRNA)IBA 01/2021
1	ChromatinIBA 01/2020
1	venetoclaxIBA 04/2018
1	Phosphotransferases (Kinase)IBA 01/2016
1	Tyrosine Kinase InhibitorsIBA 01/2016
1	CCAAT-Enhancer-Binding ProteinsIBA 05/2012